1st Annual European Congress on Immunotherapies in Cancer™

1st Annual European Congress on Immunotherapies in Cancer™


Program Chair
Antoni Ribas, MD, PhD
Professor of Medicine
Professor of Surgery
Professor of Molecular & Medical Pharmacology
David Geffen School of Medicine
Director, Tumor Immunology Program, Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Los Angeles, California, USA

Co-Chair
Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, New York, USA

European Planning Committee
Joan Carles, MD, PhD
Associate Professor of Medicine. UIC
Director GU, CNS and Sarcoma Program
Department of Medical Oncology
Vall d'Hebron University Hospital
Barcelona, Spain
 
Enriqueta Felip, MD, PhD
Director Thoracic and Head and Neck Program
Department of Medical Oncology
Vall d'Hebron University Hospital
Barcelona, Spain
 
Jose A Lopez-Martin, MD, PhD
Chairman, GETICA (Grupo Español de Terapias Inmuno-Biologicas en Cancer / Spanish Group for Cancer Immuno-Biotherapy)
Early Clinical and Translational Research Unit
Sarcoma & Melanoma Programme
Medical Oncology Department,
'12 de Octubre' University Hospital
Madrid, Spain
 
Aleix Prat, MD, PhD
Head of the Medical Oncology Department
Hospital Clinic
Associate Professor
University of Barcelona
Head of the Translational Genomics Group
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain

Faculty
Joaquim Bellmunt, MD, PhD
Director, Bladder Cancer Center
Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts, USA
 
 
Dr. Thomas Blankenstein
Research Group Leader, Max-Delbrück-Center for Molecular Medicine (MDC)
Director, Institute for Immunology, Charité – Universitätsmedizin
Berlin, Germany
 
George Coukos, MD, PhD
Director, Lausanne Branch
Ludwig Institute for Cancer Research
Lausanne, Switzerland
 
Alena Gros, PhD
Group Leader, Tumor Immunology and Immunotherapy Group
Vall d'Hebron Institute of Oncology (V.H.I.O.)
Barcelona, Spain
 
John B.A.G. Haanen, MD, PhD
Head of the Division of Medical Oncology and
Staff Scientist in the Division of Immunology
The Netherlands Cancer Institute
Amsterdam, Netherlands
Professor of Translational Immunotherapy of Cancer
Leiden University Medical Center
 
Carl H. June, MD
Richard W. Vague Professor in Immunotherapy
Department of Pathology and Laboratory Medicine
Director, Center for Cellular Immunotherapies
Director, Parker Institute for Cancer Immunotherapy
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania, USA
 
Ronald Levy, MD
Professor
Division of Oncology
Stanford School of Medicine
Stanford, California, USA
 
David F. McDermott, MD
Leader, Dana-Farber Harvard Cancer Center Kidney Cancer Program
Director, Biologic Therapy and Cutaneous Oncology Programs, Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts, USA
 
Sergio Quezada, PhD
Group Leader, Immune Regulation and Tumor Immunotherapy Lab
University College London Cancer Institute
London, United Kingdom
 
Caroline Robert, MD, PhD
Head of the Dermatology Unit, Department of Medicine
Gustave Roussy and Paris Sud University
Villejuif Grand-Paris, France
 
Jacob Schachter, MD
Head – The Ella Lemelbaum Institute for Melanoma
Division of Oncology
Sheba Medical Center
Tel Hashomer, Israel
 
Peter Schmid, FRCP, MD, PhD
Centre Lead, Centre for Experimental Cancer Medicine
Barts Cancer Institute, Queen Mary University of London
Director, Barts Breast Centre, Barts Hospital London
London, United Kingdom
 
Josep Tabernero, MD, PhD
Head, Medical Oncology Department
Vall d' Hebron University Hospital
Vall d'Hebron Institute of Oncology (V.H.I.O.)
Barcelona, Spain
 







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By